Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
24 July 1991Website:
http://www.vrtx.comNext earnings report:
04 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:58:23 GMTDividend
Analysts recommendations
Institutional Ownership
VRTX Latest News
Vertex Pharmaceuticals (VRTX) finished the most recent trading session at $476.37, which is a decrease of 0.28% compared to the previous day.
This stock may not stay below $500 for much longer.
Users of Zacks.com have been paying a lot of attention to Vertex (VRTX) lately. Therefore, it's important to understand the key information that could influence the stock's future.
At the end of the last trading day, Vertex Pharmaceuticals (VRTX) was priced at $478.09, which represents a decrease of 1.02% compared to the day before.
Vertex Pharmaceuticals (VRTX) finished the last trading day at $484.94, which is an increase of 0.67% compared to the day before.
Lately, users of Zacks.com have been focusing on Vertex (VRTX). This interest prompts a closer look at what the stock might offer.
Vertex Pharmaceuticals (VRTX) finished the last trading session at $448.16, which represents a decrease of 1.57% compared to the previous day's closing price.
At the end of the last trading day, Vertex Pharmaceuticals (VRTX) was priced at $465.08, which represents a 0.48% increase compared to the day before.
Investors frequently depend on the advice of Wall Street analysts to make choices about buying, selling, or holding stocks. News articles about these analysts from brokerage firms changing their ratings can significantly influence a stock's price.
Users of Zacks.com have been paying a lot of attention to Vertex (VRTX) lately. Therefore, it's important to understand the key information that could influence the stock's future.
What type of business is Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the development and commercialization of drug therapies for cystic fibrosis (CF) and other serious diseases. It was founded in 1989. Currently, the company's product portfolio includes medications such as SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO. These three drugs combined are approved for the treatment of approximately half of the 75,000 CF patients in North America, Europe, and Australia.
What sector is Vertex Pharmaceuticals Incorporated in?
Vertex Pharmaceuticals Incorporated is in the Healthcare sector
What industry is Vertex Pharmaceuticals Incorporated in?
Vertex Pharmaceuticals Incorporated is in the Biotechnology industry
What country is Vertex Pharmaceuticals Incorporated from?
Vertex Pharmaceuticals Incorporated is headquartered in United States
When did Vertex Pharmaceuticals Incorporated go public?
Vertex Pharmaceuticals Incorporated initial public offering (IPO) was on 24 July 1991
What is Vertex Pharmaceuticals Incorporated website?
https://www.vrtx.com
Is Vertex Pharmaceuticals Incorporated in the S&P 500?
Yes, Vertex Pharmaceuticals Incorporated is included in the S&P 500 index
Is Vertex Pharmaceuticals Incorporated in the NASDAQ 100?
Yes, Vertex Pharmaceuticals Incorporated is included in the NASDAQ 100 index
Is Vertex Pharmaceuticals Incorporated in the Dow Jones?
No, Vertex Pharmaceuticals Incorporated is not included in the Dow Jones index
When was Vertex Pharmaceuticals Incorporated the previous earnings report?
No data
When does Vertex Pharmaceuticals Incorporated earnings report?
The next expected earnings date for Vertex Pharmaceuticals Incorporated is 04 November 2024